Psilocybin Therapy Helps Clinicians Process COVID-19 Despair
University of Washington School of Medicine
In a novel study of front-line providers, the psychedelic drug reduced symptoms of depression more effectively than a placebo
depression
Intervention May Reduce Depression, Anxiety in Pregnant Women
National Institutes of Health
NIH-funded study shows prenatal mental health support is effective for women living in low-resource settings
Using Circulating mRNA in Blood as Brain Disorder Biomarkers
Johns Hopkins Medicine
Researchers used blood and organoids to study the role of mRNA carried by brain-specific EVs in PPD and psychiatric conditions
New Genes and Loci Linked to Depression Revealed
University College London
More multi-ancestry genome-wide studies can accelerate drug and treatment development for mental health conditions
Blood Biomarkers for Suicidal Ideation Identified
University of California - San Diego
Latest study suggests new way to personalize mental health care in people with treatment-refractory depression
Genetic Testing Benefits Patients with Depression, Governments Alike
University of British Columbia
Currently, pharmacogenomic tests are not offered through the public health systems across Canada
FDA Approves First Oral Treatment for Postpartum Depression
U.S. Food and Drug Administration
Multicenter clinical trials demonstrated the efficacy of Zurzuvae in women with PPD
Younger Women at Greater Risk of Rehospitalization after Heart Attacks
Swathi Kodaikal, MSc
Women’s health demands attention and intervention—more than ever before—to better understand the impact of various stressors
New, Robust, LC-MS-MS-Based Tool Detects Antidepressants in Blood
Brown University
The technique needs only 20 μl of sample and can be configured to run on most liquid handling systems
Mayo Study Lays Foundation to Predict Antidepressant Response
Mayo Clinic
Researchers identify biomarkers that correlate with response to antidepressant treatment